Pharmaceutical Technologist - September 2007 - (Page 15)

// Van Liederkerke Unsurprisingly, China and India head the list of countries for expansion, with Singapore and South Korea prime targets for MNCs. They are increasingly interested in setting up more R&D facilities and conducting more clinical trials in certain Asia territories. The region is far from homogenous and each market has its own unique challenges and opportunities. The risk landscape is complex and, while there has been significant progress on many fronts, some concerns remain. In parallel, many Asian pharmaceutical companies are looking outward and extending their geographical footprint to become pan-regional or global players. Within the region, there is a plethora of domestic companies with the likelihood of substantial consolidation. More than a third (34%) of domestic companies are looking to acquire pharmaceutical companies. More than half (52%) of these companies are seeking to acquire international market share. At present, fewer than half (45%) of the domestic companies surveyed had an international presence, but international growth is high on their agenda. Competition from generics and pricing pressures in the healthcare market continue to create pressures for cost reduction in all parts of the pharmaceutical value chain. A thirst for funding Capital constraints can be a significant brake on growth for domestic pharmaceutical companies. About half of all the domestic pharmaceutical companies surveyed in the region might look for deals if funding obstacles could be GMP biomanufacturing | GMP aseptic filling & lyophilisation | GMP cell encapsulation INOTECH Biotechnologies | Basel INOTECH Biotechnologies Ltd. | Eulerstrasse 55, P.O. Box | CH – 4003 Basel | www.inotech.ch | Phone +41 61 227 78 11 | Fax +41 61 271 83 59 | www.ptemagazine.com 15 http://www.inotech.ch http://www.inotech.ch http://www.ptemagazine.com

Table of Contents Feed for the Digital Edition of Pharmaceutical Technologist - September 2007

Contents Editor’s Comment News Morpheus Market Watch CPhI Worldwide 2007 Compliant Pharmaceutical Labelling Q&A

Pharmaceutical Technologist - September 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.